The Economics of Graduate Medical Education
The article argues that increasing direct medical education (DME) does little to offset cost of training physicians as residents pay full cost of their training and DME program only transfers money to
Research
Commitment Devices: Using Initiatives to Change Behavior
Heterogeneity in the Value of Life
We develop a numerical life-cycle model with choice over consumption and leisure, stochastic mortality and labor income processes, and calibrated to U.S.
Introduction: Philanthropy for Health in China: Distinctive Roots and Future Prospects
Drawing on the expertise of Chinese and Western academics and practitioners, the contributors to this volume aim to advance the understanding of philanthropy for health in China in the 20th century an
Assessing Incentives for Service-level Selection in Private Health Insurance Exchanges
Even with open enrollment and mandated purchase, incentives created by adverse selection may undermine the efficiency of service offerings by plans in the new health insurance Exchanges created by
Gender Income Disparities Can Be Explained by Alternative Factors—Reply
In Reply: The purpose of our study was to assess whether differences in income between male and female physicians present in the late 1980s are still present today.
Philanthropy for Health in China
Drawing on the expertise of Chinese and Western academics and practitioners, the contributors to this volume aim to advance the understanding of philanthropy for health in China in the 20th century an
The Economic Burden of Childhood Autism Spectrum Disorders
OBJECTIVE: To estimate the associations between autism spectrum disorder (ASD) diagnoses and service use, caregiver time, and cost outcomes. METHODS: We used national data from the Medical Expenditur
Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems
Medicare continues to implement payment reforms that shift reimbursement from fee-for-service toward episode-based payment, affecting average and marginal payment.
Regulating Ambiguous Risks: The Less than Rational Regulation of Pharmaceuticals
The U.S. Food and Drug Administration (FDA) balances risks and benefits before approving pharmaceuticals, as rationality would require.
Get smart & reliable public policy insights right in your inbox.